Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

about

A New Paradigm. "Learn - Learn More"; Dose-Exposure-Response at the Center of Drug Development and Regulatory Approval.

P2860

Q39248504-07687904-8723-4048-A093-C12DA55D6609

P2860

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

Item

http://www.wikidata.org/entity/Q38816602

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

@en

type

Item

label

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

@en

prefLabel

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

@en

P1476

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

@en

P2093

Matthias Schwab

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Molecular mechanism of action of metformin: old or new insights?

Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future

P304

363-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1900/RDS.2015.12.363

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Harald Staiger

Elke Schaeffeler

Hans-Ulrich Häring

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27111121

http://www.w3.org/2001/XMLSchema#string

P932

5275760

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

about

P2860

P2860

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932